Vasopressin V2 receptor antagonist

0 marketed 2 in Phase 3 1 in Phase 2

This page covers all Vasopressin V2 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Vasopressin V2 receptor, V2 receptor.

Targets

Vasopressin V2 receptor · V2 receptor

Phase 3 pipeline (2)

OPC-41061 （Tolvaptan) · Otsuka Pharmaceutical Co., Ltd. · Cardiovascular
Tolvaptan is a selective, competitive antagonist of the vasopressin V2 receptor.
Tolvaptan or Samsca · Cardiovascular Clinical Sciences Inc · Cardiovascular
Tolvaptan is a selective, competitive antagonist of the vasopressin V2 receptor.

Phase 2 pipeline (1)

BL - 1020 · BioLineRx, Ltd. · Nephrology
BL-1020 is a vasopressin V2 receptor antagonist.